IP Library Patent Application 13864108
Patent Application
App. No. 13/864,108

Method for in vitro Recombination

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/864,108
Abstract

The present invention relates to an in vitro method, using isolated protein reagents, for joining two double-stranded (ds) DNA molecules of interest, wherein the distal region of the first DNA molecule and the proximal region of the second DNA molecule share a region of sequence identity. The method allows the joining of a number of DNA fragments, in a predetermined order and orientation, without the use of restriction enzymes. It can be used, e.g., to join synthetically produced sub-fragments of a gene or genome of interest.

Claims (22)

1 . A kit for in vitro joining a plurality of dsDNA molecules, where for each pair of dsDNA molecules to be joined, a distal region of a first DNA molecule and a proximal region of a second DNA molecule share a region of overlapping sequence homology, the kit comprising:

(a) an isolated enzyme having a 3′ or 5′ exonuclease activity;

(b) an isolated non strand-displacing DNA polymerase;

(c) a ligase which is compatible with the polymerase; and

(d) a crowding agent.

2 . The kit of claim 1 wherein the exonuclease is selected from the group consisting of: T7 exonuclease, lambda exonuclease, RedA of lambda phage, and RecE of prophage.

3 . The kit of claim 1 wherein the DNA polymerase is selected from the group consisting of: T7 DNA polymerase, T4 DNA polymerase, Taq DNA polymerase, DNA polymerase I, Klenow DNA polymerase, Phi29 DNA polymerase, Pfu polymerase, VentR DNA polymerase and Deep VentR DNA polymerase.

4 . The kit of claim 1 wherein the ligase is selected from the group consisting of: Taq DNA ligase, T4 DNA ligase, and E. coli DNA ligase.

5 . The kit of claim 1 wherein the crowding agent is PEG.

6 . The kit of claim 1 , where (a), (b), (c) and (d) are in different containers.

7 . The kit of claim 1 further comprising a solution, or components for making the solution which, when combined with the exonuclease and the dsDNA molecules to be joined, comprises about 5% PEG and/or Tris buffer.

8 . The kit of claim 1 , wherein two or more of components (a), (b), (c) and (d) are in the same container.

9 . The kit of claim 1 , wherein

(a) the enzyme having an exonuclease activity is T4 DNA polymerase;

(b) the polymerase is Taq DNA polymerase; and

(c) the ligase is Taq DNA ligase and

(d) the crowding agent is PEG.

10 . The kit of claim 9 wherein the PEG ranges from PEG-200 to PEG-20000.

11 . A kit for in vitro joining a plurality of dsDNA molecules, comprising:

(a) a vessel containing purified T4 DNA polymerase;

(b) a protein that enhances annealing of single-stranded DNAs; and

(c) a ligase that is compatible with the polymerase.

Assignments (4)
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (REVOLVING) Recorded Jul 16, 2024
From: MIDCAP FUNDING IV TRUST
To: TELESIS BIO INC. (FORMERLY KNOWN AS CODEX DNA, INC.); ETONBIO, INC.
Reel/Frame 068390/0001 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (TERM) Recorded Jul 16, 2024
From: MIDCAP FINANCIAL TRUST
To: TELESIS BIO INC. (FORMERLY KNOWN AS CODEX DNA, INC.); ETONBIO, INC.
Reel/Frame 068390/0070 →
SECURITY AGREEMENT SUPPLEMENT (TERM) Recorded Jan 26, 2024
From: TELESIS BIO INC.; ETONBIO, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 066372/0745 →
SECURITY AGREEMENT SUPPLEMENT (REVOLVING) Recorded Jan 26, 2024
From: TELESIS BIO INC.; ETONBIO, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 066372/0761 →